Intrathecal baclofen for progressive neurological disease in childhood: A systematic review of literature

European Journal of Paediatric Neurology

Volumn 16, Issue 3, 2012, Pages 279-284

  Bonouvrié, Laura A ^a   Van Schie, Petra E M ^a   Becher, Jules G ^a   Van Ouwerkerk, Willem J R ^a   Vermeulen, R Jeroen ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Intrathecal baclofen; Progressive neurological disease; Spasticity

Indexed keywords

BACLOFEN;

ABDOMINAL DISCOMFORT; BACKACHE; CATHETER COMPLICATION; CEREBROSPINAL FLUID OTORRHEA; CHILDHOOD DISEASE; CONSTIPATION; DAILY LIFE ACTIVITY; DISEASE COURSE; DRUG EFFECT; DYSPHAGIA; GAIT; HUMAN; HYPERSALIVATION; HYPOTENSION; MUSCLE SPASM; NEUROLOGIC DISEASE; PAIN; PATIENT CARE; PATIENT SATISFACTION; PHYSICAL MOBILITY; PRIORITY JOURNAL; REVIEW; SCOLIOSIS; SOMNOLENCE; SPASTICITY; WITHDRAWAL SYNDROME;

ADOLESCENT; ADULT; BACLOFEN; BRAIN DISEASES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INJECTIONS, SPINAL; MALE; MUSCLE RELAXANTS, CENTRAL; MUSCLE SPASTICITY;

EID: 84860013517     PISSN: 10903798     EISSN: 15322130     Source Type: Journal    
DOI: 10.1016/j.ejpn.2011.07.008     Document Type: Review

References (27)

1. Penn R, Kroin J. Intrathecal baclofen alleviates spinal cord spasticity. Lancet 1984;1:1078. (Pubitemid 14148960)
2. Albright AL, Ferson SS. Intrathecal baclofen therapy in children. Neurosurg Focus 2006;21. e3.
3. Guillaume D, Van Havenbergh A, Vloeberghs M, Vidal J, Roeste G. A clinical study of intrathecal baclofen using a programmable pump for intractable spasticity. Arch Phys Med Rehabil 2005;86:2165-71. (Pubitemid 41566214)
4. Albright AL. Intrathecal baclofen for childhood hypertonia. Childs Nerv Syst 2007;23:971-9.
5. Latash M, Penn R. Changes in voluntary motor control induced by intrathecal baclofen in patients with spasticity of different etiology. Physiother Res Int 1996;1:229-46.
6. Albright AL, Gilmartin R, Swift D, Krach LE, Ivanhoe CB, McLaughlin JF. Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin. J Neurosurg 2003;98:291-5. (Pubitemid 36151022)
7. Sampson F, Hayward A, Evans G, Morton R, Collet B. Functional benefits and cost/benefit analysis of continuous intrathecal baclofen infusion for the management of severe spasticity. J Neurosurg 2002;96:1052-7. (Pubitemid 34579022)
8. Dan B, Motta F, Vles JSH, Vloeberghs M, Becher JG, Eunson P, et al. Consensus on the appropriate use of intrathecal baclofen (ITB therapy in paediatric spasticity. Eur J Paediatr Neurol 2010; 14:19-28.
9. Hoving MA, van Raak EPM, Spincemaille GHJJ, van Kranen- Mastenbroek VHJM, van Kleef M, Gorter JW, Vles JSH. Safety and one-year efficacy of intrathecal baclofen therapy in children with intracable spastic cerebral palsy. Eur J Paediatr Neurol 2009;13:247-56.
10. Hoving MA, van Raak EPM, Spincemaille GHJJ, Palmans LJ, Becher JG, Vles JSH. Efficacy of intrathecal baclofen therapy in children with intracable spastic cerebral palsy: a randomised controlled trial. Eur J Paediatr Neurol 2009;13:240e6.
11. Krach LE, Nettleton A, Klempka B. Satisfaction of individuals treated long-term with continuous infusion of intrathecal baclofen by implanted programmable pump. Pediatr Rehabil 2006;9:210e8.
12. Philips B, Ball C, Sackett D, Badenoch D, Straus S, Haynes B, et al. Oxford centre of evidence-based medicine levels of evidence. Oxford Centre of Evidence-based Medicine; 2001. 10.08.07. Ref Type: Electronic Citation.
13. Ben Smail D, Jacq C, Denys P, Bussel B. Intrathecal baclofen in the treatment of painful, disabling spasms in Freidreichs ataxia. Mov Disord 2005;20:758-9. (Pubitemid 41051791)
14. Chu MLY, Sala DA, Weiner HL. Intrathecal baclofen in Xlinked adrenoleukodystrophy. Pediatr Neurol 2001;24:156-8.
15. Dan B, Cheron G. Intrathecal baclofen normalizes motor strategy for squatiing in familial spastic paraplegia: a case study. Neurophysiologie Clinique 2000;30:43-8. (Pubitemid 30148767)
16. Molteni F, Carda S, Cazzaniga M, Magoni L, Rossini M, Caimmi M. Instrumental evaluation of gait modifications before and during intrathecal baclofen therapy: a 2-year follow-up case study. Am J Phys Med Rehabil 2005;84:303-6. (Pubitemid 40389072)
17. Bonouvrie LA, van Schie PE, Becher JG, van Ouwerkerk WJ, Vermeulen RJ. Satisfaction with intrathecal baclofen treatment in paediatric patients with progressive neurological disease. Dev Med Child Neurol 2008;50:636-8.
18. Kadyan V, Clairmont AC, George RJ, Johnson EW. Intrathecal baclofen for spasticity management in Rett syndrome. Am J Phys Med Rehabil 2003;82:560e2.
19. Hoving MA, Raak van EPM, Spincemaille GHJJ, Palmans LJ, Sleypen FAM, Vles JSH. Intrathecal baclofen in children with spastic cerebral palsy: a double-blind, randomized, placebocontrolled, dose-finding study. Dev Med Child Neurol 2007;49: 654-9.
20. Dan B, Bouillot E, Bengoetxea A, Cheron G. Effect of intrathecal baclofen on gait control in human hereditary spastic paraparesis. Neurosci Lett 2000;280:175-8. (Pubitemid 30089829)
21. Klebe S, Stolze H, Kopper F, Lorenz D, Wenzelburger R, Deuschl G, et al. Objective assesment of gait after intrathecal baclofen in hereditary spastic paraplegia. J Neurol 2004;252: 991-3.
22. Meythaler JM, Steers WD, Tuel SM, Cross LL, Sesco DC, Haworth CS. Intrathecal baclofen in hereditary spastic paraparesis. Arch Phys Med Rehabil 1992;73:794-7.
23. Albright AL, Turner M, Pattisapu JV. Best-practice surgical techniques for intrathecal baclofen therapy. J Neurosurg (Suppl Pediatrics) 2006;104:233-9. (Pubitemid 44968421)
24. Sansone JM, Mann D, Noonan K, Mcleish D, Ward M, Iskandar BJ. Rapid progression of scoliosis following insertion of intrathecal baclofen pump. J Pediatr Orthop 2006; 26:125-8. (Pubitemid 44385825)
25. Shilt JS, Lai LP, Cabrera MN, Frino J, Smith BP. The impact of intrathecal baclofen on the natural history of scoliosis in cerebral palsy. J Pediatr Orthopaedics 2008;28:684-7.
26. Senaran H, Shah SA, Presedo A, Dabney KW, Glutting JW, Miller F. The risk of progression of scoliosis in cerebral palsy patients after intrathecal baclofen therapy. Spine 2007;32: 2348-54. (Pubitemid 47508843)
27. Lambrecq V, Muller F, Joseph PA, Cuny E, Mazaux JM, Barat M. Intérêts et limites du baclofène dans les paraparésies spastiques héréditaires. Ann Readapt Med Phys 2007;50:577-81.